CMV infections in thalassemia patients after BMT.
Baronciani
D
D
Divisione Ematologica, Ospedale di Pesaro, Italy.
Polchi
P
P
Lucarelli
G
G
Filocamo
M
M
Galimberti
M
M
Angelucci
E
E
Durazzi
S M
SM
Giardini
C
C
Bartolucci
M
M
D000293:Adolescent; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000209:etiology*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008297:Male; D013789:Thalassemia / Q000628:therapy*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D002066:Busulfan